Related Experiment Video
Updated: Aug 5, 2026

05:17
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
Published on: April 18, 2025
What Do Persistent Misclassifications Tell Us About Alzheimer's Disease Detection using Structural MRI?
Didem Stark1,2, Hwajin Shin1,2, Nicolas Münster1,2
1Hertie Institute for AI in Brain Health, University of Tübingen, Germany.
Medrxiv : the Preprint Server for Health Sciences
|August 1, 2026
Summary
Deep learning models for Alzheimer's Disease (AD) detection struggle with certain patient subtypes. Persistent misclassifications highlight the need to account for disease heterogeneity in artificial intelligence (AI) development.
Area of Science:
- Neuroimaging
- Artificial Intelligence
- Neurology
Background:
- Deep learning (DL) models show promise in detecting Alzheimer's Disease (AD) using structural MRI (sMRI).
- Systematic analysis of DL model failure modes in AD detection is limited.
- Understanding misclassification patterns is crucial for improving AI diagnostic tools.
Purpose of the Study:
- To investigate persistent misclassification patterns in DL models for AD detection.
- To characterize subjects who are consistently misclassified by DL models.
- To explore whether persistent false negatives in AD detection are due to disease staging or atypical presentation.
Main Methods:
- Trained two DL architectures to classify AD from cognitively normal (CN) participants using sMRI data from the ADNI dataset.
- Examined persistent misclassifications across 100 model instances and various training configurations.
- Analyzed longitudinal sMRI scans to assess changes in DL model predictions over time.
Main Results:
- Identified a subgroup of subjects persistently misclassified across multiple DL models.
- These persistently misclassified subjects showed distinct atrophy patterns, including hippocampal-sparing and minimal atrophy subtypes.
- Changes in DL model predictions (false negative to true positive) occurred in a subset of subjects over intervals up to five years.
Conclusions:
- Persistent misclassification in DL-based AD detection may not solely be explained by disease progression or staging.
- Disease heterogeneity, characterized by distinct atrophy subtypes, significantly impacts DL model performance.
- Clinical AI model development for AD detection must consider and address disease variability for improved accuracy and reliability.
Related Concept Videos
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
